List of Kapspargo Sprinkle drug patents

Kapspargo Sprinkle is owned by Spil.

Kapspargo Sprinkle contains Metoprolol Succinate.

Kapspargo Sprinkle has a total of 2 drug patents out of which 0 drug patents have expired.

Kapspargo Sprinkle was authorised for market use on 26 January, 2018.

Kapspargo Sprinkle is available in capsule, extended release;oral dosage forms.

The generics of Kapspargo Sprinkle are possible to be released after 09 July, 2035.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9700530 SPIL Capsule dosage form of metoprolol succinate
Jul, 2035

(12 years from now)

US9504655 SPIL Capsule dosage form of metoprolol succinate
Jul, 2035

(12 years from now)

Drugs and Companies using METOPROLOL SUCCINATE ingredient

Market Authorisation Date: 26 January, 2018

Treatment: NA

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic